EPAMAR STRONG Omega-3
(Salmon Oil-vitamin E Capsule)

• EPAMAR STRONG Omega-3 , a registered food supplement, is made of high quality Salmon oil which contains high amount of essential fatty acids (n-3 fatty acids).
• n-3 fatty acids (synonymous, omega-3 fatty acids) are long-chain polyunsaturated fatty acids. Species of this lipid class that naturally occur in appreciable amounts are Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA) and alpha-linolenic acid.
• In the past 2 decades, views about dietary n-3 fatty acids have moved from speculation about their functions to solid evidence that they are not only essential nutrients but also may favorably modulate many diseases.
• One capsule contains salmon oil 500 mg.
• Daily dosage, 4 capsules of EPAMAR STRONG Omega-3  contains 100% of daily need (RDA):

  Eicosapentaenoic acid (EPA)...........335 mg
  Docosahexaenoic acid (DHA)............223 mg
  Vitamin E..............................10 mg
  

• Dosage: 4 capsules a day. Not recommended for children or for people whose blood coagulation function is beyond normal range.
• Package: 72 capsules/50 g , 120 capsules/84 g
• EPAMAR Omega-3 (Oil) is also available.

• n-3 fatty acids favorably affect atherosclerosis, coronary heart disease, inflammatory disease, and perhaps even behavioral disorders.
• Recent studies show dietary intake of n-3 fatty acids and weekly consumption of fish may reduce the risk of incident Alzheimer disease.
• n-3 fatty acids are especially important for normal fetal and infant growth and development and for brain development and visual activity in particular.
• Increased dietary or parenteral intake of these fatty acids affects a large number of biochemical and functional parameters in human body. Epidemiologic and biochemical studies over the past 20 years, have suggested that these changes translate into a beneficial effect on the course of lipid disorders and of some inflammatory and cardiovascular diseases.
• The protective effects of n-3 fatty acids have been explained based on changes in eicosanoid synthesis and the reduced risk of sudden death from cardiac arrhythmia, increased protection from ischemic myocardium, improved myocardial function and reduction of other cardiovascular and autoimmune disease risks.
• Vitamin E is an important antioxidant protecting cells from free radical damages.

References

1. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.
   Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
   Arch Neurol. 2006 Oct;63(10):1402-8.
2. La Guardia M, Giammanco S, Di Majo D, Tabacchi G, Tripoli E, Giammanco M.
   Omega 3 fatty acids: biological activity and effects on human health.
   Panminerva Med. 2005 Dec;47(4):245-57. Review.
3. Blood profiles, body fat and mood state in healthy subjects on different diets supplemented with Omega-3 polyunsaturated fatty acids.
   Fontani G, et al.
   Eur J Clin Invest. 2005 Aug;35(8):499-507.
4. Circulating adiponectin and plasma fatty acid profile.
   Fernandez-Real JM, Vendrell J, Ricart W.
   Clin Chem. 2005 Mar;51(3):603-9.
5. Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis.
   Seierstad SL, Seljeflot I, Johansen O, Hansen R, Haugen M, Rosenlund G, Froyland L, Arnesen H.
   Eur J Clin Invest. 2005 Jan;35(1):52-9.
6. Omega-3 for baby and me: material development for a WIC intervention to increase DHA intake during pregnancy.
   Troxell H, et al
   Matern Child Health J. 2005 Jun;9(2):189-97.
7. Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
   Grynberg A.
   Curr Pharm Des. 2005;11(4):489-509.
8. Multiple sclerosis and nutrition.
   Schwarz S, Leweling H.
   Mult Scler. 2005 Feb;11(1):24-32.
9. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women.
   Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, Willett WC, Hu FB.
   J Nutr. 2004 Jul;134(7):1806-11.
10. The natural treatment of hypertension.
    Wilburn AJ, King DS, Glisson J, Rockhold RW, Wofford MR.
    J Clin Hypertens (Greenwich). 2004 May;6(5):242-8.
11. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schneider J.
    Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.
    Arch Neurol. 2003 Jul;60(7):940-6.
12. Penny M. Kris-Etherton, PhD, RD; William S. Harris, PhD; Lawrence J. Appel, MD, MPH for the Nutrition Committee
    Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease .
    Circulation. 2002;106:2747
13. Petersen M, Pedersen H, Major-Pedersen A, Jensen T, Marckmann P.
    Effect of Fish Oil Versus Corn Oil Supplementation on LDL and HDL Subclasses in Type 2 Diabetic Patients. .
    Diabetes Care 2002 Oct;25(10):1704-8
14. Oomen CM, Feskens EJ, Rasanen L, Fidanza F, Nissinen AM, Menotti A, Kok FJ, Kromhout D
    Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands.
    Am J Epidemiol 2000 May 15;151(10):999-1006
15. Connor WE
    Importance of n-3 fatty acids in health and disease.
    Am J Clin Nutr 2000 Jan;71(1 Suppl):171S-5S
16. Spector AA
    Essentiality of fatty acids.
    Lipids 1999;34 Suppl:S1-3
17. Kang JX, Leaf A
    Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids.
    Am J Clin Nutr 2000 Jan;71(1 Suppl):202S-7S
18. Leaf A, Kang JX, Xiao YF, Billman GE
    Dietary n-3 fatty acids in the prevention of cardiac arrhythmias.
    Curr Opin Clin Nutr Metab Care 1998 Mar;1(2):225-8
19. Leaf A, Kang JX, Xiao YF, Billman GE, Voskuyl RA
    The antiarrhythmic and anticonvulsant effects of dietary N-3 fatty acids.
    J Membr Biol 1999 Nov 1;172(1):1-11
20. Kromhout D
    Fatty acids, antioxidants, and coronary heart disease from an epidemiological perspective.
    Lipids 1999;34 Suppl:S27-31
21. Nordoy A
    Dietary fatty acids and coronary heart disease.
    Lipids 1999;34 Suppl:S19-22

    (References searched and cited from National Library of Medicine-PubMed at http://www.ncbi.nlm.nih.gov/PubMed/ )

     This site edited and maintained by Yu Heci

    The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.

    Updated November 3, 2006